Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.

MLA

Nicolì, F., et al. “Correlation between Serum Anti-TSH Receptor Autoantibodies (TRAbs) and the Clinical Feature of Graves’ Orbitopathy.” Journal of Endocrinological Investigation, vol. 44, no. 3, Mar. 2021, pp. 581–85. EBSCOhost, https://doi.org/10.1007/s40618-020-01353-y.

APA

Nicolì, F., Lanzolla, G., Mantuano, M., Ionni, I., Mazzi, B., Leo, M., Sframeli, A., Posarelli, C., Maglionico, M. N., Figus, M., Nardi, M., Marcocci, C., & Marinò, M. (2021). Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy. Journal of Endocrinological Investigation, 44(3), 581–585. https://doi.org/10.1007/s40618-020-01353-y

Chicago

Nicolì, F, G Lanzolla, M Mantuano, I Ionni, B Mazzi, M Leo, A Sframeli, et al. 2021. “Correlation between Serum Anti-TSH Receptor Autoantibodies (TRAbs) and the Clinical Feature of Graves’ Orbitopathy.” Journal of Endocrinological Investigation 44 (3): 581–85. doi:10.1007/s40618-020-01353-y.